Beijing Geekgene Technology Co., Ltd

This early-stage trial tests a new cell therapy called GK01 in 10 adults with advanced solid tumors that have not responded to standard treatments. The main goal is to check safety and how the body processes the therapy, while also looking at whether it can shrink tumors or slow …

This early-phase study tests an experimental cell therapy called GK01 in 15 adults with advanced solid tumors (like stomach or lung cancer) that have stopped responding to standard treatments. The main goals are to find the safest dose and check for side effects. Researchers will…